HealthGilead pill succeeds in mid-stage bowel disease trial

Gilead Sciences said on Monday that its experimental once-daily pill eased symptoms of a chronic bowel illness in more patients than a placebo in a mid-stage trial.

Gilead Sciencesbowel diseasedrug trial

RReuters★★☆☆☆2026-10-19 15:10Original